2009
DOI: 10.1002/aoc.1500
|View full text |Cite
|
Sign up to set email alerts
|

Simple route to ferrocenylalkyl nucleobases. Antitumor activity in vivo

Abstract: Ferrocenylalkyl nucleobases (1-14) were prepared via the reaction of the α-(hydroxy)alkyl ferrocenes FcCHR(OH) (Fc = ferrocenyl; R = H, Me, Et, Ph) with thymine, cytosine, iodo-cytosine and adenine in DMSO at 100• C, yields being 50-80%. The antitumor activities of ferrocenylmethyl thymine (1) against solid tumor models, carcinoma 755 (Ca755) and Lewis lung carcinoma (LLC) were studied in vivo. Therapeutic synergism of antitumor activity against LLC was demonstrated in the case of combined application of compo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
52
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 62 publications
(53 citation statements)
references
References 36 publications
0
52
0
1
Order By: Relevance
“…At the same time at higher doses, 1.0 and 5.0 mg kg −1 , the effects of ferrocene were significantly lower. Such an inverse dose-effect response was found for ferrocenylmethyl benzimidazole [3b] (Lewis lung carcinoma, dose 5.0 mg kg −1 , tumor growth inhibition 70%), o-carboxybenzoylferrocene sodium salt [3d] (carcinoma 755, dose 2.5 mg kg −1 , tumor growth inhibition 70%), feroocenylmethyl thymine [10] (carcinoma 755, dose 2.5 mg kg −1 , tumor growth inhibition 70%) and the other ferrocene derivatives. [3a] The anomalies in dose-effect response may be connected to the increased immunogenicity of the ferrocene derivatives.…”
Section: Antitumor Activitymentioning
confidence: 91%
See 3 more Smart Citations
“…At the same time at higher doses, 1.0 and 5.0 mg kg −1 , the effects of ferrocene were significantly lower. Such an inverse dose-effect response was found for ferrocenylmethyl benzimidazole [3b] (Lewis lung carcinoma, dose 5.0 mg kg −1 , tumor growth inhibition 70%), o-carboxybenzoylferrocene sodium salt [3d] (carcinoma 755, dose 2.5 mg kg −1 , tumor growth inhibition 70%), feroocenylmethyl thymine [10] (carcinoma 755, dose 2.5 mg kg −1 , tumor growth inhibition 70%) and the other ferrocene derivatives. [3a] The anomalies in dose-effect response may be connected to the increased immunogenicity of the ferrocene derivatives.…”
Section: Antitumor Activitymentioning
confidence: 91%
“…[13] Recently therapeutic synergism of the antitumor activity of a combination of ferrocenylmethyl thymine with the wellknown antitumor drug cyclophosphamide against Ca755 was demonstrated. [10] All these results are important for the further investigation of ferrocene compounds as prospective drugs for antitumor polychemotherapy.…”
Section: Introductionmentioning
confidence: 94%
See 2 more Smart Citations
“…The two drug systems operate by different cell killing mechanisms [1,[4][5][6], and it was of interest here to establish potentiating or additive effects [3], if any, in subsequent bio-evaluation work [2]. The conjugation was achieved by amide bond formation, resulting from reaction of drug-connected carboxylic acid function of the drugs with amine function of the carriers.…”
Section: Introductionmentioning
confidence: 99%